Notice Number: NOT-AI-17-045
Key Dates
Release Date: October 4, 2017
PAR-15-287
Issued by
National Institute of Allergy and Infectious Diseases (NIAID)
Purpose
The purpose of this Notice is to inform potential applicants that effective immediately, NIAID will no longer be participating in PAR-15-287, "Opportunities for Collaborative Research at the NIH Clinical Center (U01)".
PAR-15-287 has been updated in the following ways to reflect NIAID's withdrawal from this FOA:
Part 1. Overview Information
Components of Participating Organizations
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
National Cancer Institute (NCI)
National Eye Institute (NEI)
National Heart, Lung, and Blood Institute (NHLBI)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Complementary and Integrative Health (NCCIH)
Office of Dietary Supplements (ODS)
Office of Research on Women’s Health (ORWH)
National Human Genome Research Institute (Institute (NHGRI)
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.865; 93.233; 93.839; 93.838; 93.837; 93.286; 93.273; 93.173; 93.399; 93.396; 93.395; 93.394; 93.393; 93.279; 93.173; 93.242; 93.853; 93.846; 93.213; 93.867; 93.847; 93.321; 93.172
Part 2. Full Text of Announcement
Section I. Funding Opportunity Description
The following language has been removed from the FOA
NIAID
The mission of the National Institute of Allergy and Infectious Diseases (NIAID) is to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases. To accomplish its mission, NIAID conducts and supports a comprehensive portfolio of research on the biology, pathogenesis, and host response to microbes; the mechanisms of normal immune function and immune dysfunction resulting in autoimmunity, immunodeficiency, allergy, and transplant rejection; and translational research to develop vaccines, therapeutics, and diagnostics to prevent and treat the many infectious, immune-mediated, and allergic diseases that afflict people throughout the world. Investigators are encouraged to visit the NIAID website for additional information about the research mission and high-priority research areas of the NIAID http://www3.niaid.nih.gov/about/whoWeAre/planningPriorities/.)
Section VII. Agency Contacts
The following contacts are deleted from the FOA
Scientific/Research Contact(s)
NIAID
Kenneth E. Santora, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2933
Email: [email protected]
Matthew J. Fenton, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-496-7291
Email: [email protected]
Financial/Grants Management Contact(s)
NIAID
Tina M. Carlisle
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-402-6579
Email: [email protected]
All other aspects of the FOA remain the same.
Inquiries
Please direct all inquiries to:
Kenneth E. Santora, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-669-2933
Email: [email protected]
Matthew J. Fenton, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 301-496-7291
Email: [email protected]
and Human Services (HHS)
